首页> 美国卫生研究院文献>Acta Crystallographica Section F: Structural Biology and Crystallization Communications >Preparation and crystallization of the Grb7 SH2 domain in complex with the G7-18NATE nonphosphorylated cyclic inhibitor peptide
【2h】

Preparation and crystallization of the Grb7 SH2 domain in complex with the G7-18NATE nonphosphorylated cyclic inhibitor peptide

机译:与G7-18NATE非磷酸化环状抑制剂肽复合的Grb7 SH2结构域的制备和结晶

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Grb7 is an adapter protein that is involved in signalling pathways that mediate eukaryotic cell proliferation and migration. Its overexpression in several cancer types has implicated it in cancer progression and led to the development of the G7-18NATE cyclic peptide inhibitor. Here, the preparation of crystals of G7-­18NATE in complex with its Grb7 SH2 domain target is reported. Crystals of the complex were grown by the hanging-drop vapour-diffusion method using PEG 3350 as the precipitant at room temperature. X-ray diffraction data were collected from crystals to 2.4 Å resolution using synchrotron X-ray radiation at 100 K. The diffraction was consistent with space group P21, with unit-cell parameters a = 52.7, b = 79.1, c = 54.7 Å, α = γ = 90.0, β = 104.4°. The structure of the G7-18NATE peptide in complex with its target will facilitate the rational development of Grb7-targeted cancer therapeutics.
机译:Grb7是一种衔接蛋白,参与介导真核细胞增殖和迁移的信号通路。它在几种癌症类型中的过表达与癌症进展有关,并导致了G7-18NATE环肽抑制剂的发展。在此,报道了与Grb7 SH2结构域靶标复合的G7-18NATE晶体的制备。在室温下,使用PEG 3350作为沉淀剂,通过悬滴蒸汽扩散法生长复合物的晶体。使用同步辐射X射线在100 K下从晶体收集X射线衍射数据至2.4Å分辨率。衍射与空间群P21一致,单位晶胞参数a = 52.7,b = 79.1,c = 54.7, α=γ= 90.0,β= 104.4°。 G7-18NATE肽及其靶标复合物的结构将促进针对Grb7的癌症治疗药物的合理开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号